Hassel, J.C.; Zimmer, L.; Sickmann, T.; Eigentler, T.K.; Meier, F.; Mohr, P.; Pukrop, T.; Roesch, A.; Vordermark, D.; Wendl, C.;
et al. Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15, 3448. Cancers 2025, 17, 3726.
https://doi.org/10.3390/cancers17233726
AMA Style
Hassel JC, Zimmer L, Sickmann T, Eigentler TK, Meier F, Mohr P, Pukrop T, Roesch A, Vordermark D, Wendl C,
et al. Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15, 3448. Cancers. 2025; 17(23):3726.
https://doi.org/10.3390/cancers17233726
Chicago/Turabian Style
Hassel, Jessica C., Lisa Zimmer, Thomas Sickmann, Thomas K. Eigentler, Friedegund Meier, Peter Mohr, Tobias Pukrop, Alexander Roesch, Dirk Vordermark, Christina Wendl,
and et al. 2025. "Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15, 3448" Cancers 17, no. 23: 3726.
https://doi.org/10.3390/cancers17233726
APA Style
Hassel, J. C., Zimmer, L., Sickmann, T., Eigentler, T. K., Meier, F., Mohr, P., Pukrop, T., Roesch, A., Vordermark, D., Wendl, C., & Gutzmer, R.
(2025). Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 2023, 15, 3448. Cancers, 17(23), 3726.
https://doi.org/10.3390/cancers17233726
